Research
Hormonal
GLP-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes and obesity due to benefits in glycemic control, weight loss, and cardiovascular risk reduction.
Practitioners should consider GLP-1 RAs for managing type 2 diabetes and obesity.
StrongSupportsmedium confidence
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used to treat type 2 diabetes and obesity due to their benefits in glycemic control, weight loss, and cardiovascular risk reduction.
Why this rating
The claim is based on established clinical use and benefits.
Source
GLP-1 Receptor Agonists: Clinical Considerations and Risk Management for Patients Undergoing Ophthalmic Surgery
Caroline R. Baumal et al. · Ophthalmic surgery, lasers & imaging retina · 2026
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →